Marsh & McLennan Companies (NYSE:MMC) posted Thursday second-quarter earnings that rose past the average analyst estimate as revenue momentum continued across its business units, along with acquisition tailwinds.

Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall biotechnology sector, as investors repositioned portfolios ahead of the release of

Stocks jumped to record highs on Thursday, with investors brushing off the latest Trump-Powell drama to focus on strong earnings and robust economic data.

PepsiCo offers strong dividend growth potential with a stable credit rating and a 14% discount on fair value. Click here to read my most recent analysis.

Live Updates Live Coverage Updates appear automatically as they are published. Segment Analysis 6:22 am by Eric Bleeker Let’s take a look at Taiwan Semiconductor’s different segments last quarter: Taiwan Semiconductor Investor Relations As you can see,